Publication 2023 12

Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy. Metz R, Rauscher A, Vaugier L, Supiot S, Drouet F, Campion L, Rousseau C. Cancers. 2023, 15: 1898. https://doi.org/10.3390/cancers15061898